(Q40956450)

English

Differential binding of viral peptides to HLA-A2 alleles. Implications for human papillomavirus type 16 E7 peptide-based vaccination against cervical carcinoma

scientific article published on April 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 September 2017

Differential binding of viral peptides to HLA-A2 alleles. Implications for human papillomavirus type 16 E7 peptide-based vaccination against cervical carcinoma (English)

1 reference

Europe PubMed Central

25 September 2017

author name string

Ressing ME

1

1 reference

Europe PubMed Central

25 September 2017

de Jong JH

2

1 reference

Europe PubMed Central

25 September 2017

Brandt RM

3

1 reference

Europe PubMed Central

25 September 2017

Drijfhout JW

4

1 reference

Europe PubMed Central

25 September 2017

Benckhuijsen WE

5

1 reference

Europe PubMed Central

25 September 2017

Schreuder GM

6

1 reference

Europe PubMed Central

25 September 2017

Offringa R

7

1 reference

Europe PubMed Central

25 September 2017

Kast WM

8

1 reference

Europe PubMed Central

25 September 2017

Melief CJ

9

1 reference

Europe PubMed Central

25 September 2017

language of work or name

0 references

publication date

1 April 1999

1 reference

Europe PubMed Central

25 September 2017

European Journal of Immunology

1 reference

Europe PubMed Central

25 September 2017

29

1 reference

Europe PubMed Central

25 September 2017

4

1 reference

Europe PubMed Central

25 September 2017

1292-1303

1 reference

Europe PubMed Central

25 September 2017

Genetic polymorphism within HLA-A*02: significant allelic variation revealed in different populations.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199904%2929%3A04%3C1292%3A%3AAID-IMMU1292%3E3.0.CO%3B2-6

21 January 2018

Genetic diversity of HLA-A2: evolutionary and functional significance

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199904%2929%3A04%3C1292%3A%3AAID-IMMU1292%3E3.0.CO%3B2-6

21 January 2018

Structure of the HLA-A*0204 antigen, found in South American Indians. Spatial clustering of HLA-A2 subtype polymorphism

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199904%2929%3A04%3C1292%3A%3AAID-IMMU1292%3E3.0.CO%3B2-6

21 January 2018

Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199904%2929%3A04%3C1292%3A%3AAID-IMMU1292%3E3.0.CO%3B2-6

21 January 2018

Molecular analysis of the association of HLA-B53 and resistance to severe malaria

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199904%2929%3A04%3C1292%3A%3AAID-IMMU1292%3E3.0.CO%3B2-6

21 January 2018

HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199904%2929%3A04%3C1292%3A%3AAID-IMMU1292%3E3.0.CO%3B2-6

21 January 2018

Structure of the human class I histocompatibility antigen, HLA-A2

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199904%2929%3A04%3C1292%3A%3AAID-IMMU1292%3E3.0.CO%3B2-6

21 January 2018

Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199904%2929%3A04%3C1292%3A%3AAID-IMMU1292%3E3.0.CO%3B2-6

21 January 2018

The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199904%2929%3A04%3C1292%3A%3AAID-IMMU1292%3E3.0.CO%3B2-6

21 January 2018

Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199904%2929%3A04%3C1292%3A%3AAID-IMMU1292%3E3.0.CO%3B2-6

21 January 2018

Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199904%2929%3A04%3C1292%3A%3AAID-IMMU1292%3E3.0.CO%3B2-6

21 January 2018

The HLA-A*0207 peptide binding repertoire is limited to a subset of the A*0201 repertoire

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199904%2929%3A04%3C1292%3A%3AAID-IMMU1292%3E3.0.CO%3B2-6

21 January 2018

Estimates of the worldwide incidence of eighteen major cancers in 1985.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199904%2929%3A04%3C1292%3A%3AAID-IMMU1292%3E3.0.CO%3B2-6

21 January 2018

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199904%2929%3A04%3C1292%3A%3AAID-IMMU1292%3E3.0.CO%3B2-6

21 January 2018

Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199904%2929%3A04%3C1292%3A%3AAID-IMMU1292%3E3.0.CO%3B2-6

21 January 2018

HLA-A2 subtypes are functionally distinct in peptide binding and presentation

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199904%2929%3A04%3C1292%3A%3AAID-IMMU1292%3E3.0.CO%3B2-6

21 January 2018

Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199904%2929%3A04%3C1292%3A%3AAID-IMMU1292%3E3.0.CO%3B2-6

21 January 2018

Isolation of an immunodominant viral peptide that is endogenously bound to the stress protein GP96/GRP94.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199904%2929%3A04%3C1292%3A%3AAID-IMMU1292%3E3.0.CO%3B2-6

21 January 2018

Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199904%2929%3A04%3C1292%3A%3AAID-IMMU1292%3E3.0.CO%3B2-6

21 January 2018

Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199904%2929%3A04%3C1292%3A%3AAID-IMMU1292%3E3.0.CO%3B2-6

21 January 2018

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199904%2929%3A04%3C1292%3A%3AAID-IMMU1292%3E3.0.CO%3B2-6

21 January 2018

Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199904%2929%3A04%3C1292%3A%3AAID-IMMU1292%3E3.0.CO%3B2-6

21 January 2018

Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199904%2929%3A04%3C1292%3A%3AAID-IMMU1292%3E3.0.CO%3B2-6

21 January 2018

A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199904%2929%3A04%3C1292%3A%3AAID-IMMU1292%3E3.0.CO%3B2-6

21 January 2018

Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicity

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199904%2929%3A04%3C1292%3A%3AAID-IMMU1292%3E3.0.CO%3B2-6

21 January 2018

Peptide-based cancer vaccines

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199904%2929%3A04%3C1292%3A%3AAID-IMMU1292%3E3.0.CO%3B2-6

21 January 2018

HLA supertypes and supermotifs: a functional perspective on HLA polymorphism

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199904%2929%3A04%3C1292%3A%3AAID-IMMU1292%3E3.0.CO%3B2-6

21 January 2018

An HLA class I peptide-binding assay based on competition for binding to class I molecules on intact human B cells. Identification of conserved HIV-1 polymerase peptides binding to HLA-A*0301

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199904%2929%3A04%3C1292%3A%3AAID-IMMU1292%3E3.0.CO%3B2-6

21 January 2018

Monoclonal antibody to HLA-A3

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199904%2929%3A04%3C1292%3A%3AAID-IMMU1292%3E3.0.CO%3B2-6

21 January 2018

Definition of unique and shared T-cell defined tumor antigens in human renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199904%2929%3A04%3C1292%3A%3AAID-IMMU1292%3E3.0.CO%3B2-6

21 January 2018

Identifiers

10.1002/(SICI)1521-4141(199904)29:04<1292::AID-IMMU1292>3.0.CO;2-6

1 reference

Europe PubMed Central

25 September 2017

1 reference

Europe PubMed Central

25 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40956450&oldid=1911131609"